A Tunable Glycosaminoglycan-Peptide Nanoparticle Platform for the Protection of Therapeutic Peptides
The popularity of Glycosaminoglycans (GAGs) in drug delivery systems has grown as their innate ability to sequester and release charged molecules makes them adept in the controlled release of therapeutics. However, peptide therapeutics have been relegated to synthetic, polymeric systems, despite the...
Saved in:
Main Authors: | Harkanwalpreet Sodhi (Author), Alyssa Panitch (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimating peptide half‐life in serum from tunable, sequence‐related physicochemical properties
by: Marco Cavaco, et al.
Published: (2021) -
Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction
by: James R. Wodicka, et al.
Published: (2017) -
Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice
by: Andrey E. Karateev, et al.
Published: (2023) -
Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide
by: Mijeong Bak, et al.
Published: (2020) -
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
by: Aditya Vivek Joglekar, et al.
Published: (2022)